Abstracts

ISOLATION OF TRANSLOCATING BACTERIA IN PROGRESSIVE SIV INFECTION OF RHESUS MACAQUES

Microbial translocation is commonly observed in HIV-infected humans and is a significant contributor to chronic immune activation and inflammation. In SIV-infected Asian macaques, translocation has been demonstrated to occur across the gastrointestinal barrier; however, translocating bacterial taxa are not representative of the gut microbiota, with Proteobacteria appearing to preferentially translocate. To fully characterize translocating bacterial…

ANTIBIOTICS DISRUPT COLONIC MICROBIOTA AND MUCOSAL IMMUNE FUNTION IN RHESUS MACAQUES

Antibiotics are widely used throughout the world to treat bacterial infections that occur independently or as a result of HIV infection. However, evidence suggests that antibiotic treatments disrupt the composition of the intestinal microbiome. Further, HIV infection is associated with disrupted microbiota and mucosal dysfunction independent of antibiotic use. Intestinal microbiota are critical for maintaining…

EFFECT OF PROBIOTICS ON GUT MICROBIOTA AND PET/MRI ACTIVITY IN HIV-INFECTED PERSONS

Despite combination antiretroviral therapy (cART) with suppressed viral replication, gut microbiota alterations, microbial translocation and low-grade inflammation persist in several HIV-infected individuals. The aim of this study was to investigate the effects of the probiotic strain Lactobacillus rhamnosus GG (LGG) on the gut microbiota composition, microbial translocation and intestinal inflammation. The gut microbiota composition (Illumina…

INVESTIGATING THE EFFECT OF THERAPEUTICS ON THE MICROBIOME OF PATIENTS WITH HIV/AIDS

Here, we investigate the pathways by which maraviroc-treated cohorts experience improved mucosal immunity through changes in host:microbial interactions. We hypothesize that maraviroc therapy-induced improvements in mucosal immunity impacts the microbial mucosal interaction through either a change in the distribution of the microbial communities, their metabolic state, or both. We previously performed a three-arm, randomized clinical…

TLR9 AGONIST MODULATED INTESTINAL GLYCOGENE EXPRESSION IMPACTS MICROBIOME DIVERSITY

An emerging paradigm suggests that the gut-associated glycome is critical to the maintenance of a homeostatic relationship between the host and its gut microbiota. In HIV infection, alterations in glycan metabolism may contribute to HIV-mediated intestinal damage, microbial translocation, and chronic inflammation. Given that we recently found that the TLR9 agonist lefitolimod (MGN1703, Mologen AG)…

HIV-ASSOCIATED CHANGES OF THE GUT MICROBIOME IN ARV-TREATED, UNTREATED, & CONTROLLERS

HIV infection is associated with gut microbiome alterations, enteropathy, and intestinal translocation of microbial products. It is unclear what HIV associated changes in the gut microbiome occur in HIV-infected individuals who control the disease immunologically without treatment, but they provide a unique model to investigate the effects of HIV infection. Our Boston cohort (n=183), the…